Josh Drumm | Investor Relations |
Peter Hoang | President and Chief Executive Officer |
Richard Kenney | Head-Clinical Development |
Michael Loiacono | Chief Financial Officer |
Jack Roseman | Private Investor |
Jerry Logan | Private Investor |
Good afternoon. And welcome to the TapImmune Third Quarter 2017 Business Update Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.